JPRN-jRCT2080221457未知1 期
A Phase 1 Study of LY2523355 in Patients with Solid Cancer
Kyowa Hakko Kirin Co., Ltd.0 个研究点开始时间: 2011年5月17日最近更新:
试验速览
- 阶段
- 1 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Histological and/or cytological evidence of solid tumors
- •- A diagnosis of advanced and/or metastatic solid tumors
- •- Patients who are refractory to standard therapy or for which no proven effective therapy exists
- •- Written informed consent
- •- Appropriate bone marrow, hepatic and renal functions
- •- ECOG PS =< 1
排除标准
- •- Have serious preexisting complication
- •- Have active infection which requires intravenous antibiotics
- •- Have symptomatic central nervous system metastases
- •- Have current acute or chronic leukemia
- •- Have had an autologous or allogenic hematopoietic stem cell transplantation
- •- Have active multiple cancers
研究者
相似试验
招募中
1 期
Study of LY3537982 in Cancer Patients with a Specific Genetic Mutation (KRAS G12C)SCLCCRCEndometrial NeoplasmsOvarian NeoplasmsPancreatic NeoplasmsBiliary Tract NeoplasmsFrontline, 1L, First LineJPRN-jRCT2031210265Masaki Takeshi80
未知
2 期
Phase II clinical study of TY-51924 in patients with acute myocardial infarction - Pilot studyAcute myocardial infarctionJPRN-jRCT2080221349TOA EIYO LTD.
未知
2 期
Proof of concept study of TY-51924 in patients with acute myocardial infarctioAcute myocardial infarctionJPRN-jRCT2080221705TOA EIYO LTD.100
进行中（未招募）
不适用
Study with Myeloproliferative NeoplasmsMyeloproliferative NeoplasmsMedDRA version: 14.1Level: HLTClassification code 10028578Term: Myeloproliferative disorders (excl leukaemias)System Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2011-001012-56-ESilly S.A150
进行中（未招募）
1 期
A Study of LY2784544 in patients with blood cancerEUCTR2011-001012-56-DEEli Lilly and Company121